Evidence map›Paper›PMID 29030466›Full record

ArticleJournal of the American Society of Nephrology : JASN2018

Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.

Liad Hinden, Shiran Udi, Adi Drori, Asaad Gammal, Alina Nemirovski, Rivka Hadar, Saja Baraghithy, Anna Permyakova, Matan Geron, Merav Cohen and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Hepatic targeting of the centrally active cannabinoid 1 receptor (CBJournal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  16. Cannabinoid Signaling in the Diabetic Proximal Tubule: Of Mice and Men.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2023
    Article
  17. Review
  18. Metabolites · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Liad HindenObesity and Metabolism Laboratory.
Shiran UdiObesity and Metabolism Laboratory.
Adi DroriObesity and Metabolism Laboratory.
Asaad GammalObesity and Metabolism Laboratory.
Alina NemirovskiObesity and Metabolism Laboratory.ORCID 0000-0002-2598-0119
Rivka HadarObesity and Metabolism Laboratory.
Saja BaraghithyObesity and Metabolism Laboratory.
Anna PermyakovaObesity and Metabolism Laboratory.
Matan GeronCellular and Molecular Pain Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, and.
Merav CohenThe Alexander Grass Center for Bioengineering, Benin School of Computer and Science Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.
Sabina Tsytkin-KirschenzweigThe Alexander Grass Center for Bioengineering, Benin School of Computer and Science Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.
Yael RiahiEndocrinology and Metabolism Service, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Gil LeibowitzEndocrinology and Metabolism Service, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Yaakov NahmiasThe Alexander Grass Center for Bioengineering, Benin School of Computer and Science Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.
Avi PrielCellular and Molecular Pain Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, and.
Joseph TamObesity and Metabolism Laboratory, yossit@ekmd.huji.ac.il.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Altered glucose reabsorption

Indexed as

AlbuminuriaAnimalsBiological TransportBlood GlucoseBlood Urea NitrogenCreatinineDiabetic NephropathiesDogsFibrosisGlucoseGlucose Transporter Type 2InsulinIslets of LangerhansKidney Tubules, ProximalMadin Darby Canine Kidney CellsMale3-(4-chlorophenyl)-N-methyl-N'-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidineBlood GlucoseCNR1 protein, mouseCreatinineGlucoseGlucose Transporter Type 2InsulinJD5037Protein Kinase C betaPyrazolesReceptor, Cannabinoid, CB1Slc2a2 protein, mouseStreptozocinSulfonamidesCB1 Receptordiabetic nephropathyEndocannabinoidsGLUT2Renal Proximal Tubule Cells

Identifiers

PMID29030466
PMCPMC5791066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.